Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms

ClinicalTrials.gov ID: NCT05312567

Public ClinicalTrials.gov record NCT05312567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 8:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Plac.-Controlled Clinical Study to Compare the Efficacy of FP-101 60mg b.i.d. vs. Placebo for the Treatment of Moderate-to-Severe Hot Flashes in Peri- and Post-menopausal Women Over a Period of 1-Week.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase II proof of concept study is designed to assess the safety and efficacy of FP-101 (60mg b.i.d.), an extended-release oral tablet product, compared to a matching placebo in the treatment of moderate-to-severe hot flashes in peri- and post-menopausal women over a period of 1-week.

Study identification

NCT ID
NCT05312567
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Fervent Pharmaceuticals
Industry
Enrollment
105 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
46 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 24, 2021 (Actual)
Primary completion
Apr 5, 2023 (Actual)
Completion
Jul 31, 2023 (Actual)
Last update posted
Oct 26, 2023

2021 – 2023

United States locations

U.S. sites
12
U.S. states
6
U.S. cities
11
Facility City State ZIP Site status
Torrance Clinical Research Institute Lomita California 90717 —
Long Beach Clinical Trial Services Long Beach California 90806 —
Provideré Research Inc. West Covina California 91790 —
Inpatient Research Clinic Hialeah Florida 33013 —
The Angel Medical Research Corporation Miami Lakes Florida 33016 —
Suncoast Clinical Research - Pasco County New Port Richey Florida 34652 —
Cary Medical Group Cary North Carolina 27518 —
Raleigh Medical Group Raleigh North Carolina 27609 —
Clinical Research of Philadelphia Philadelphia Pennsylvania 19114 —
Coastal Carolina Research Center North Charleston South Carolina 29405 —
ICON Early Phase Services San Antonio Texas 78209 —
Discovery Clinical Trials - Stone Oak San Antonio Texas 78258 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05312567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2023 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05312567 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →